Florida is far more than a collection of theme parks, water parks, and breezy beaches. There are just as many places to visit when you need an adults-only escape, and some of the state's top resorts ...

St. Augustine began life in 1565 making it one of the oldest cities in the U.S.A., if not the oldest. It is home to Ponce de ...

The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...

Eight months after announcing the $18.5 million first tranche of its series A, Augustine Therapeutics has closed the ...

AGT-100216 will now enter a Phase I/II proof-of-concept clinical trial for CMT disease, with patient enrolment set to begin ...

Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the ...

Leuven, Belgium-based Augustine Therapeutics NV, a biotechnology company, has secured €77.7M in an oversubscribed Series A funding round co-led by Novo ...

HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...

Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while ...

On Tuesday, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with ...

On Tuesday, Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. The expansion will evaluate the combination of ...

Developed internally at Lilly, Kisunla is the first and only amyloid plaque-targeting therapy that uses a limited-duration treatment regimen. In phase 3 trials of 1,736 patients, Kisunla slowed ...